CLOSE

Trials of hydroxychloroquine in the treatment of corona will resume: WHO


Switzerland, Ta. 4 June 2020, Thursday

The World Health Organization (WHO) has decided to reintroduce the hydroxychloroquine drug used in the treatment of malaria as a trial in the treatment of corona. The trial of hydroxychloroquine will be resumed on Wednesday, World Health Organization President Tedros Adnom Gabreyes said.

Earlier, the World Health Organization (WHO) had stopped the trial of hydroxychloroquine, saying it was harmful to health. During a virtual news briefing, Tedros said, "Given the available death toll, the executive group will inform principal investigators about resuming trials of hydroxychloroquine."

The trial of the drug was halted last week due to security concerns. A report said there was no evidence that hydroxychloroquine was beneficial and that the health organization had since banned it.

This drug called hydroxychloroquine is used to treat malaria. Most of the companies manufacturing this drug are based in India. Last month, India lifted the ban on the drug at the request of US President Trump.

Comments

Popular posts from this blog

These special 5 tips for women to always stay fit, stay healthy and healthy

To keep the body hydrated in the heat, eat it today. Fruits and vegetables

Despite Corona Report Positive, 85% of Patients Have Symptoms Absent?

Approval to set up oxygen plants in 162 hospitals of the country to alleviate the shortage, 3 will be done in Gujarat

New risk of 'Tomato Flu' in South India, 80 children rushed to Zapate, Learn Symptoms and Remedies

Lamentation over the death of 12 corona patients in a single hospital with low oxygen pressure

Corona infection can recur within 50 days: Study

Is steroid treatment responsible for causing myocardial infarction?

Iced Green Tea: Apart from providing relief from heat, this drink also helps in weight loss

Not antibodies but T-cells are a guarantee of immunity against corona, know how it works